These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 16574099)

  • 1. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
    Nagasawa T; Inada Y; Nakano S; Tamura T; Takahashi T; Maruyama K; Yamazaki Y; Kuroda J; Shibata N
    Eur J Pharmacol; 2006 Apr; 536(1-2):182-91. PubMed ID: 16574099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis.
    Yu J; Chu ES; Hui AY; Cheung KF; Chan HL; Leung WK; Farrell GC; Sung JJ
    Biochem Biophys Res Commun; 2007 Apr; 356(1):53-9. PubMed ID: 17350593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages
    Lefere S; Puengel T; Hundertmark J; Penners C; Frank AK; Guillot A; de Muynck K; Heymann F; Adarbes V; Defrêne E; Estivalet C; Geerts A; Devisscher L; Wettstein G; Tacke F
    J Hepatol; 2020 Oct; 73(4):757-770. PubMed ID: 32360434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
    Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I
    Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet.
    Nakagami H; Shimamura M; Miyake T; Shimosato T; Minobe N; Moritani T; Kiomy Osako M; Nakagami F; Koriyama H; Kyutoku M; Shimizu H; Katsuya T; Morishita R
    Mol Med Rep; 2012 Jan; 5(1):37-40. PubMed ID: 21946918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet.
    Lee KC; Chan CC; Yang YY; Hsieh YC; Huang YH; Lin HC
    PLoS One; 2013; 8(10):e77817. PubMed ID: 24204981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
    Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Yoshida T; Akiba J; Matsui T; Nakamura K; Hisamoto T; Abe M; Ikezono Y; Wada F; Iwamoto H; Nakamura T; Koga H; Yamagishi SI; Torimura T
    Dig Dis Sci; 2017 Jun; 62(6):1527-1536. PubMed ID: 28365916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-beta1 in a cultured stellate cell line.
    Nakano S; Nagasawa T; Ijiro T; Inada Y; Tamura T; Maruyama K; Kuroda J; Yamazaki Y; Kusama H; Shibata N
    Hepatol Res; 2008 Oct; 38(10):1026-39. PubMed ID: 18513333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice.
    Yamaguchi K; Itoh Y; Yokomizo C; Nishimura T; Niimi T; Fujii H; Okanoue T; Yoshikawa T
    Lab Invest; 2010 Aug; 90(8):1169-78. PubMed ID: 20368703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
    Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
    Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.
    Ip E; Farrell G; Hall P; Robertson G; Leclercq I
    Hepatology; 2004 May; 39(5):1286-96. PubMed ID: 15122757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice.
    Chen T; Zhong FJ; Hong YM; Su WJ; Zhuang LL; Qiu LX
    Chin J Nat Med; 2014 Mar; 12(3):194-8. PubMed ID: 24702805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conophylline inhibits non-alcoholic steatohepatitis in mice.
    Nakade Y; Sakamoto K; Yamauchi T; Inoue T; Kobayashi Y; Yamamoto T; Ishii N; Ohashi T; Sumida Y; Ito K; Nakao H; Fukuzawa Y; Umezawa K; Yoneda M
    PLoS One; 2017; 12(6):e0178436. PubMed ID: 28594915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
    Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
    Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
    Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.